Last updated: 2026-10-05 16:04:00. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Johnson & Johnson (JNJ) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $253.97, with a market capitalisation of $617.01B and a P/E ratio of 29.33. Over the past 52 weeks, its price has ranged from $182.94 to $281.07. This page covers its latest market performance, valuation, price trends and company information.
$617.01B | |
$256.00 | |
$281.07 | |
$46.25 | |
$256.03 | |
3.24M | |
7.05M | |
29.33 | |
$281.07 | |
$182.94 | |
2.05% | |
-- |
Johnson & Johnson (JNJ) is currently trading at $253.97 as of 2026-10-05 15:48:55, down 0.80% ($2.06) from the previous close of $256.03
During today's regular trading session, JNJ has traded between $46.25 and $281.07, with a trading volume of 3.24M shares. The current price is near the upper end of today's range.
Over the past seven days, Johnson & Johnson (JNJ) moved from $270.68 to $253.97, representing a decline of 6.17% ($16.71).
The stock traded between $252.92 and $275.23 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 6.97 million shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 72.4%
JNJ is currently trading at $253.97, placing it 72.4% of the way from its 52-week low of $182.94 to its 52-week high of $281.07. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 140800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Johnson & Johnson (JNJ) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.